Aceto reported 192.23M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acasti Pharma ACST:US C$ 36.93M 14.01M
Aceto ACET:US 192.23M 16.5M
Agile Therapeutics AGRX:US $ 14.74M 11.38M
Glaxosmithkline GSK:US $ 3453M 50M
Idera Pharmaceuticals IDRA:US $ 36.6M 3.99M
Novartis NVS:US $ 7211M 2094M
Pain Therapeutics PTIE:US $ 241.52M 36.73M
Prestige Brands PBH:US $ 42.82M 120.81M
Quaker Chemical KWR:US $ 141.39M 4.22M